{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:16:29Z","timestamp":1790284589863,"version":"4.1.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG026572"],"award-info":[{"award-number":["P01AG026572"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG061897"],"award-info":[{"award-number":["T32AG061897"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["5R01AG057931-02"],"award-info":[{"award-number":["5R01AG057931-02"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Translational validity of mouse models of Alzheimer\u2019s disease (AD) is variable. Because change in weight is a well-documented precursor of AD, we investigated whether diversity of human AD risk weight phenotypes was evident in a longitudinally characterized cohort of 1,196 female and male humanized APOE (hAPOE) mice, monitored up to 28 months of age which is equivalent to 81 human years. Autoregressive Hidden Markov Model (AHMM) incorporating age, sex, and APOE genotype was employed to identify emergent weight trajectories and phenotypes. In the hAPOE-AD mouse cohort, five distinct weight trajectories emerged: three trajectories were associated with a weight loss phenotype (36% of mice, n = 426), one with weight gain (13% of mice, n = 152), and one trajectory of no change in weight (34% of mice, n = 403). The AHMM model findings were validated with post-hoc survival analyses, revealing differences in survival rates across the five identified phenotypes. Further validation was performed using body composition and plasma \u03b2-amyloid data from mice within the identified gain, loss and stable weight trajectories. Weight gain trajectory was associated with elevated plasma \u03b2-amyloid levels, higher body fat composition, lower survival rates and a greater proportion of APOE4\/4 carriers. In contrast, weight loss was associated with greater proportion of hAPOE3\/4 carriers, better survival rates and was predominantly male. The association between weight change and AD risk observed in humans was mirrored in the hAPOE-AD mouse model. Weight trajectories of APOE3\/3 mice were equally distributed across weight gain, loss and stability. Surprisingly, despite genetic uniformity, comparable housing, diet and handling, distinct weight trajectories and divergence points emerged for subpopulations. These data are consistent with the heterogeneity observed in the human population for change in body weight during aging and highlight the importance of longitudinal phenotypic characterization of mouse aging to advance the translational validity of preclinical AD mouse models.<\/jats:p>","DOI":"10.1371\/journal.pone.0314097","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T18:32:59Z","timestamp":1737743579000},"page":"e0314097","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Weight trajectories in aging humanized APOE mice with translational validity to human Alzheimer\u2019s risk population: A retrospective analysis"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2916-6402","authenticated-orcid":true,"given":"Francesca","family":"Vitali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Parker-Halstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Diaz Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"issue":"4","key":"pone.0314097.ref001","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/alz.12638","article-title":"2022 Alzheimer\u2019s disease facts and figures","volume":"18","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"12","key":"pone.0314097.ref002","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical Alzheimer\u2019s disease and mild cognitive impairment in the United States (2020\u20132060).","volume":"17","author":"KB Rajan","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"1","key":"pone.0314097.ref003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer\u2019s Disease.","volume":"388","author":"CH van Dyck","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"pone.0314097.ref004","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer\u2019s Disease.","volume":"9","author":"S Budd Haeberlein","year":"2022","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"5","key":"pone.0314097.ref005","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamaneurol.2022.0315","article-title":"Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US","volume":"79","author":"EL Ross","year":"2022","journal-title":"JAMA Neurology"},{"issue":"2","key":"pone.0314097.ref006","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020335","article-title":"The Future of Precision Medicine in the Cure of Alzheimer\u2019s Disease.","volume":"11","author":"A Arafah","year":"2023","journal-title":"Biomedicines"},{"issue":"456","key":"pone.0314097.ref007","article-title":"A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer\u2019s Disease.","volume":"11","author":"H Hampel","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"pone.0314097.ref008","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/healthcare6030082","article-title":"Precision Medicine for Alzheimer\u2019s Disease Prevention.","volume":"6","author":"CL Berkowitz","year":"2018","journal-title":"Healthcare"},{"issue":"3","key":"pone.0314097.ref009","doi-asserted-by":"crossref","first-page":"e59825","DOI":"10.1371\/journal.pone.0059825","article-title":"Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer\u2019s","volume":"8","author":"F Ding","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"pone.0314097.ref010","doi-asserted-by":"crossref","first-page":"e79977","DOI":"10.1371\/journal.pone.0079977","article-title":"Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer\u2019s mouse brain: implication for bioenergetic intervention","volume":"8","author":"F Ding","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"pone.0314097.ref011","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.ebiom.2015.11.002","article-title":"White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer\u2019s Disease.","volume":"2","author":"LP Klosinski","year":"2015","journal-title":"EBioMedicine"},{"issue":"3","key":"pone.0314097.ref012","doi-asserted-by":"crossref","first-page":"e0151710","DOI":"10.1371\/journal.pone.0151710","article-title":"Weight loss predicts progression of mild cognitive impairment to Alzheimer\u2019s disease.","volume":"11","author":"I Cova","year":"2016","journal-title":"PloS one."},{"issue":"3","key":"pone.0314097.ref013","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1532-5415.1996.tb00912.x","article-title":"Weight change in Alzheimer\u2019s disease.","volume":"44","author":"H White","year":"1996","journal-title":"J Am Geriatr Soc"},{"issue":"78","key":"pone.0314097.ref014","doi-asserted-by":"crossref","first-page":"34691","DOI":"10.18632\/oncotarget.26162","article-title":"Obesity and Alzheimer\u2019s disease, does the obesity paradox really exist? A magnetic resonance imaging study","volume":"9","author":"J Pegueroles","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"pone.0314097.ref015","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1038\/s41598-021-82593-7","article-title":"Body mass index trajectories and the risk for Alzheimer\u2019s disease among older adults.","volume":"11","author":"SY Kang","year":"2021","journal-title":"Scientific Reports."},{"issue":"1","key":"pone.0314097.ref016","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/WAD.0000000000000005","article-title":"Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease.","volume":"28","author":"LM Besser","year":"2014","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"7","key":"pone.0314097.ref017","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3390\/nu15071795","article-title":"Longitudinal Examination of Body Mass Index and Cognitive Function in Older Adults: The HELIAD Study.","volume":"15","author":"I Grapsa","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"pone.0314097.ref018","first-page":"e12163","article-title":"Body weight changes and longitudinal associations with cognitive decline among community\u2010dwelling older adults.","volume":"13","author":"H Eymundsdottir","year":"2021","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring."},{"key":"pone.0314097.ref019","first-page":"1","article-title":"Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer\u2019s Disease in an Observational Cohort Study","author":"F Morys","year":"2022","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"pone.0314097.ref020","article-title":"Increase in skeletal muscular adiposity and cognitive decline in a biracial cohort of older men and women.","author":"C Rosano","year":"2023","journal-title":"J Am Geriatr Soc."},{"issue":"9","key":"pone.0314097.ref021","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/archneur.63.9.1312","article-title":"Accelerated weight loss may precede diagnosis in Alzheimer disease","volume":"63","author":"DK Johnson","year":"2006","journal-title":"Archives of Neurology"},{"issue":"1","key":"pone.0314097.ref022","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010063","article-title":"The Synergistic Effects of APOE Genotype and Obesity on Alzheimer\u2019s Disease Risk.","volume":"20","author":"NS Jones","year":"2018","journal-title":"Int J Mol Sci."},{"issue":"8","key":"pone.0314097.ref023","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/gerona\/glab117","article-title":"Body Mass Index and Polygenic Risk for Alzheimer\u2019s Disease Predict Conversion to Alzheimer\u2019s Disease.","volume":"76","author":"JN Moody","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"pone.0314097.ref024","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12967-022-03621-2","article-title":"Body mass index, genetic susceptibility, and Alzheimer\u2019s disease: a longitudinal study based on 475,813 participants from the UK Biobank","volume":"20","author":"S Yuan","year":"2022","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"pone.0314097.ref025","first-page":"e12110","article-title":"Model organism development and evaluation for late\u2010onset Alzheimer\u2019s disease: MODEL\u2010AD.","volume":"6","author":"AL Oblak","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions."},{"issue":"1","key":"pone.0314097.ref026","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-024-00712-0","article-title":"Updates on mouse models of Alzheimer\u2019s disease.","volume":"19","author":"MZ Zhong","year":"2024","journal-title":"Molecular neurodegeneration."},{"key":"pone.0314097.ref027","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.procs.2015.09.151","article-title":"Autoregressive Hidden Markov Model and the Speech Signal.","volume":"61","author":"JD Bryan","year":"2015","journal-title":"Procedia Computer Science"},{"issue":"5","key":"pone.0314097.ref028","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1109\/JBHI.2013.2294692","article-title":"Autoregressive hidden Markov models for the early detection of neonatal sepsis","volume":"18","author":"I Stanculescu","year":"2013","journal-title":"IEEE journal of biomedical and health informatics"},{"key":"pone.0314097.ref029","doi-asserted-by":"crossref","first-page":"105571","DOI":"10.1016\/j.cmpb.2020.105571","article-title":"Bimodal affect recognition based on autoregressive hidden Markov models from physiological signals","volume":"195","author":"FP Akbulut","year":"2020","journal-title":"Computer Methods and Programs in Biomedicine"},{"issue":"2","key":"pone.0314097.ref030","doi-asserted-by":"crossref","first-page":"1729881419834840","DOI":"10.1177\/1729881419834840","article-title":"Analysis of multimodal Bayesian nonparametric autoregressive hidden Markov models for process monitoring in robotic contact tasks","volume":"16","author":"H Wu","year":"2019","journal-title":"International Journal of Advanced Robotic Systems"},{"issue":"6","key":"pone.0314097.ref031","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research","volume":"8","author":"C Kilkenny","year":"2010","journal-title":"PLOS Biology"},{"issue":"7","key":"pone.0314097.ref032","doi-asserted-by":"crossref","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"N Percie du Sert","year":"2020","journal-title":"PLOS Biology"},{"key":"pone.0314097.ref033","unstructured":"ShepherdShack\u00ae. Available from: https:\/\/www.ssponline.com\/products\/shepherd-shack\/."},{"issue":"510","key":"pone.0314097.ref034","first-page":"126","article-title":"A gentle tutorial of the EM algorithm and its application to parameter estimation for Gaussian mixture and hidden Markov models","volume":"4","author":"JA Bilmes","year":"1998","journal-title":"International computer science institute"},{"issue":"1\u20132","key":"pone.0314097.ref035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0004-3702(99)00062-4","article-title":"Lazy propagation: a junction tree inference algorithm based on lazy evaluation","volume":"113","author":"AL Madsen","year":"1999","journal-title":"Artificial Intelligence"},{"issue":"3","key":"pone.0314097.ref036","article-title":"A package for survival analysis in R","volume":"3","author":"T. Therneau","year":"2020","journal-title":"R package version."},{"key":"pone.0314097.ref037","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/B978-012369454-6\/50074-1","volume-title":"The Mouse in Biomedical Research (Second Edition).","author":"K Flurkey","year":"2007"},{"issue":"3","key":"pone.0314097.ref038","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archneurol.2011.31","article-title":"Cognitive decline in prodromal alzheimer disease and mild cognitive impairment","volume":"68","author":"RS Wilson","year":"2011","journal-title":"Archives of Neurology"},{"issue":"1","key":"pone.0314097.ref039","first-page":"143","article-title":"Association Between Late-Life Weight Change and Dementia: A Population-based Cohort Study","volume":"78","author":"J Guo","year":"2022","journal-title":"The Journals of Gerontology: Series A."},{"issue":"16","key":"pone.0314097.ref040","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.3390\/ijms20163892","article-title":"Ketogenic diet in alzheimer\u2019s disease","volume":"20","author":"M Rusek","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"pone.0314097.ref041","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/advances\/nmz054","article-title":"The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diets Are Associated with Less Cognitive Decline and a Lower Risk of Alzheimer\u2019s Disease-A Review.","volume":"10","author":"AC Van Den Brink","year":"2019","journal-title":"Advances in Nutrition."},{"key":"pone.0314097.ref042","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.nut.2018.10.003","article-title":"The ketogenic diet as a potential treatment and prevention strategy for Alzheimer\u2019s disease.","volume":"60","author":"GM Broom","year":"2019","journal-title":"Nutrition"},{"issue":"3","key":"pone.0314097.ref043","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3233\/JAD-170248","article-title":"Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer\u2019s Disease and Late-Life Cognitive Disorders: A Systematic Review","volume":"59","author":"V Solfrizzi","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"pone.0314097.ref044","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","article-title":"Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer\u2019s disease markers in subjects with mild cognitive impairment","volume":"47","author":"R Nagpal","year":"2019","journal-title":"EBioMedicine"},{"issue":"2","key":"pone.0314097.ref045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3233\/JAD-180160","article-title":"Nutritional Intervention to Prevent Alzheimer\u2019s Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined","volume":"64","author":"JM Nolan","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"9","key":"pone.0314097.ref046","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jalz.2014.11.009","article-title":"MIND diet associated with reduced incidence of Alzheimer\u2019s disease","volume":"11","author":"MC Morris","year":"2015","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"pone.0314097.ref047","article-title":"Plasma Amyloid-\u03b2 Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity","author":"ES Brook","year":"2023","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"pone.0314097.ref048","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000235555","article-title":"Plasma amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals","volume":"90","author":"YH Lee","year":"2009","journal-title":"Neuroendocrinology"},{"issue":"4","key":"pone.0314097.ref049","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/ije\/dyaa099","article-title":"Higher risk of dementia in English older individuals who are overweight or obese","volume":"49","author":"Y Ma","year":"2020","journal-title":"International Journal of Epidemiology"},{"issue":"2","key":"pone.0314097.ref050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-160114","article-title":"An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia","volume":"53","author":"W Li","year":"2016","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"8","key":"pone.0314097.ref051","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/brainsci11081036","article-title":"Association between visceral fat and brain structural changes or cognitive function","volume":"11","author":"N Ozato","year":"2021","journal-title":"Brain Sciences"},{"issue":"2","key":"pone.0314097.ref052","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jcsm.12380","article-title":"Cachexia and advanced dementia","volume":"10","author":"C Minaglia","year":"2019","journal-title":"Journal of Cachexia, Sarcopenia and Muscle."},{"issue":"1","key":"pone.0314097.ref053","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3233\/JAD-220998","article-title":"Patterns of Aging Changes in Bodyweight May Predict Alzheimer\u2019s Disease","volume":"97","author":"S Ukraintseva","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"pone.0314097.ref054","doi-asserted-by":"crossref","first-page":"1359202","DOI":"10.3389\/fragi.2024.1359202","article-title":"How are APOE4, changes in body weight, and longevity related? Insights from a causal mediation analysis.","volume":"5","author":"R Holmes","year":"2024","journal-title":"Front Aging."},{"issue":"10","key":"pone.0314097.ref055","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s12603-017-0906-3","article-title":"Late-life body mass index, rapid weight loss, apolipoprotein E \u03b54 and the risk of cognitive decline and incident dementia","volume":"21","author":"SP Bell","year":"2017","journal-title":"The Journal of nutrition, health and aging."},{"issue":"2","key":"pone.0314097.ref056","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S1041610294001705","article-title":"Weight Loss in Alzheimer\u2019s Disease: An International Review of the Literature.","volume":"6","author":"GP Wolf-Klein","year":"1994","journal-title":"International Psychogeriatrics."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0314097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T18:33:19Z","timestamp":1737743599000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0314097"}},"subtitle":[],"editor":[{"given":"Maud","family":"Gratuze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0314097","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}